Review
doi: 10.1016/s0003-3928(03)00067-2.
[Drug-eluting stents in complex lesions]
[Article in
French]
Affiliations
- PMID: 12938571
- DOI: 10.1016/s0003-3928(03)00067-2
Item in Clipboard
Review
[Drug-eluting stents in complex lesions]
[Article in
French]
Ann Cardiol Angeiol (Paris).
2003 Jun.
Abstract
Interventional cardiology has evolved tremendously over the past two years with the advent of drug-eluting stents. The RAVEL trial was the first randomized study conducted with sirolimus-eluting stents in a selected population of patients in whom a 0% rate of binary restenosis was achieved. The objective of the SIRIUS trial conducted in a more complex patient population was to test the efficacy of the sirolimus-eluting stent in high-risk settings such as coronary bifurcation lesions.
Similar articles
-
[In-stent restenosis: which indications for drug-eluting stent?].Ann Cardiol Angeiol (Paris). 2003 Jun;52(3):198-9. doi: 10.1016/s0003-3928(03)00066-0. Ann Cardiol Angeiol (Paris). 2003. PMID: 12938576 French.
-
Drug eluting stents: initial experiences.Z Kardiol. 2002;91 Suppl 3:44-8. doi: 10.1007/s00392-002-1309-x. Z Kardiol. 2002. PMID: 12641014
-
[When are drug-eluting stents effective? A critical analysis of the presently available data].Z Kardiol. 2004 Sep;93(9):649-63. doi: 10.1007/s00392-004-0143-8. Z Kardiol. 2004. PMID: 15365732 Review. German.
-
[Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (< or = 2.25 mm). Insights from the DIABETES trial].Rev Esp Cardiol. 2006 Oct;59(10):1000-7. doi: 10.1157/13093976. Rev Esp Cardiol. 2006. PMID: 17125709 Spanish.
-
Sirolimus-eluting stents: a review of experimental and clinical findings.Z Kardiol. 2002;91 Suppl 3:49-57. doi: 10.1007/s00392-002-1310-4. Z Kardiol. 2002. PMID: 12641015 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
